PTAB To Eye Cancer Treatment IP Over EU Branch Objections
The Patent Trial and Appeal Board has agreed to review a cancer treatment patent owned by a German university and an atomic energy organization associated with the European Commission....To view the full article, register now.
Already a subscriber? Click here to view full article